References
- Mendola P, Mumford SL, Männistö TI, et al. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology. 2015;26(1):17–26.
- Perak AM, Lancki N, Kuang A, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Associations of gestational cardiovascular health with pregnancy outcomes: the hyperglycemia and adverse pregnancy outcome study. Am J Obstet Gynecol. 2021;224(2):210.e1–210.e17.
- Hooijschuur MCE, Ghossein-Doha C, Kroon AA, et al. Metabolic syndrome and pre-eclampsia. Ultrasound Obstet Gynecol. 2019;54(1):64–71.
- Possomato-Vieira JS, Khalil RA. Mechanisms of endothelial dysfunction in hypertensive pregnancy and preeclampsia. Adv Pharmacol. 2016;77:361–431.
- Yu W, Gao W, Rong D, et al. Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia. Microcirculation. 2019;26(4):e12508.
- Salzer L, Tenenbaum-Gavish K, Hod M. Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia). Best Pract Res Clin Obstet Gynaecol. 2015;29(3):328–338.
- Hooijschuur MC, Ghossein-Doha C, Al-Nasiry S, et al. Maternal metabolic syndrome, preeclampsia, and small for gestational age infancy. Am J Obstet Gynecol. 2015;213(3):370.e1–370.e7.
- Nahum Sacks K, Friger M, Shoham-Vardi I, et al. Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring. Pregnancy Hypertens. 2018;13:181–186.
- Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497.
- Alonso-Ventura V, Li Y, Pasupuleti V, et al. Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and meta-analysis. Metabolism. 2020;102:154012.
- Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
- Ahmed R, Dunford J, Mehran R, et al. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014;63(18):1815–1822.
- Hauspurg A, Countouris ME, Jeyabalan A, et al. Risk of hypertension and abnormal biomarkers in the first year postpartum associated with hypertensive disorders of pregnancy among overweight and obese women. Pregnancy Hypertens. 2019;15:1–6.
- Dall’Asta A, D’Antonio F, Saccone G, et al. Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57(5):698–709.
- Wu P, Kwok CS, Haththotuwa R, et al. Pre-eclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis. Diabetologia. 2016;59(12):2518–2526.
- Valdés E, Sepúlveda-Martínez A, Manukián B, et al. Assessment of pregestational insulin resistance as a risk factor of preeclampsia. Gynecol Obstet Invest. 2014;77(2):111–116.
- Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Curr Diab Rep. 2015;15(3):9.